68Ga-NOTA-PRGD2 PET/CT for integrin imaging in patients with lung cancer

Journal of Nuclear Medicine

Volumn 56, Issue 12, 2015, Pages 1823-1827

  Zheng, Kun ^a   Liang, Naixin ^a   Zhang, Jingjing ^a   Lang, Lixin ^b   Zhang, Wei ^a   Li, Shanqing ^a   Zhao, Jun ^c   Niu, Gang ^b   Li, Fang ^a   Zhu, Zhaohui ^a   Chen, Xiaoyuan ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^c CANCER HOSPITAL   (China)

Author keywords

68Ga NOTA PRGD2; Integrin; Lung cancer; Lymph node metastasis; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 68; RADIOPHARMACEUTICAL AGENT; VITRONECTIN RECEPTOR; 68GALLIUM-BNOTA-PRGD2; COORDINATION COMPOUND; CYCLOPEPTIDE; INTEGRIN;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CHRONIC INFLAMMATION; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG DISTRIBUTION; DRUG SAFETY; FEMALE; GRANULOMA; HAMARTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPOMA; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TUBERCULOSIS; VERY ELDERLY; IMAGE PROCESSING; LUNG TUMOR; LYMPH NODE; METABOLISM; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SCINTISCANNING; WHOLE BODY IMAGING; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COORDINATION COMPLEXES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INTEGRINS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 84954265636     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.115.160648     Document Type: Article

References (36)

1. Niu G, Chen X. Why integrin as a primary target for imaging and therapy. Theranostics. 2011;1:30-47.
2. Mizejewski GJ. Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med. 1999;222:124-138.
3. Varner JA, Cheresh DA. Integrins and cancer. Curr Opin Cell Biol. 1996;8:724-730.
4. Felding-Habermann B, Fransvea E, O'Toole TE, Manzuk L, Faha B, Hensler M. Involvement of tumor cell integrin avb3 in hematogenous metastasis of human melanoma cells. Clin Exp Metastasis. 2002;19:427-436.
5. Brooks PC, Montgomery AM, Rosenfeld M, et al. Integrin avb3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994;79:1157-1164.
6. v integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest. 1999;103:1227-1230.
7. 3-targeted imaging of lung cancer. Neoplasia. 2005;7:271-279.
8. Mousa SA. Anti-integrin as novel drug-discovery targets: potential therapeutic and diagnostic implications. Curr Opin Chem Biol. 2002;6:534-541.
9. 99mTc-labeled Arg-Gly-Asp (RGD) peptide in rats with ischemic acute renal failure. J Am Soc Nephrol. 1996;7:2682-2688.
10. 3 in a preclinical tumor model. Cancer Biother Radiopharm. 2008;23:691-700.
11. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl Med Biol. 2004;31:179-189.
12. 64Cu-labeled dimeric RGD peptides. Mol Imaging Biol. 2004; 6:350-359.
13. 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1, 4, 7-triazacyclononane-1, 4, 7-triacetic acid and feasibility studies in mice. J Nucl Med. 2008;49:830-836.
14. 3 expression. Eur J Nucl Med Mol Imaging. 2008;35: 1100-1108.
15. 89Zr-RGD peptides. Mol Imaging Biol. 2011;13:1224-1233.
16. 111In-labeled RGD peptide. Nucl Med Biol. 2007;34:29-35.
17. 3 integrin expression. Mol Imaging Biol. 2010;12:530-538.
18. 68Ga-RGD positron emission tomography in pediatric cerebral infarct. Mol Imaging. 2013;12:213-217.
19. 68Ga-labelled mono-, di-and tetrameric RGD peptides. Eur J Nucl Med Mol Imaging. 2011;38:128-137.
20. 68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice. Bioconjug Chem. 2011;22:2415-2422.
21. Chang AJ, Dehdashti F, Bradley JD. The role of positron emission tomography for non-small cell lung cancer. Pract Radiat Oncol. 2011;1:282-288.
22. Billé A, Pelosi E, Skanjeti A, et al. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg. 2009;36:440-445.
23. 68Ga-NOTA-RGD, a positron emission tomography agent for angiogen-esis imaging. Cancer Biother Radiopharm. 2012;27:65-71.
24. 3 expression. J Nucl Med. 2006;47:763-769.
25. 18F-AH111585 in breast cancer patients. J Nucl Med. 2008;49:879-886.
26. 18F-AH111585 in healthy volunteers. J Nucl Med. 2008;49:1664-1667.
27. 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination. J Nucl Med. 2013;54:691-698.
28. 3 integrin levels. Radiology. 2011;260:182-191.
29. 3 with RGD PET/CT in suspected lung cancer patients. Eur J Nucl Med Mol Imaging. July 9, 2015 [Epub ahead of print].
30. Freudenberg LS, Rosenbaum SJ, Beyer T, Bockisch A, Antoch G. PET versus PET/CT dual-modality imaging in evaluation of lung cancer. Radiol Clin North Am. 2007;45:639-644.
31. Deppen S, Putnam JB Jr, Andrade G, et al. Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease. Ann Thorac Surg. 2011;92:428-432.
32. Deppen SA, Blume JD, Kensinger CD, et al. Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis. JAMA. 2014;312:1227-1236.
33. Iskender I, Kapicibasi HO, Kadioglu SZ, et al. Comparison of integrated positron emission tomography/computed tomography and mediastinoscopy in mediastinal staging of non-small cell lung cancer: analysis of 212 patients. Acta Chir Belg. 2012;112:219-225.
34. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? J Nucl Med. 2007;48:1761-1766.
35. 18F]galacto-RGD identifies the level of integrin avb3 expression in man. Clin Cancer Res. 2006;12:3942-3949.
36. 3 expression in human carotid atherosclerosis. JACC Cardiovasc Imaging. 2014;7:178-187.